---
title: "眼科製藥和醫療技術公司 Glaukos Corporation（GKOS）一度跌約 14.7%，創 5 月 1 日以來最大盤中跌幅。"
description: "眼科製藥和醫療技術公司 Glaukos Corporation（GKOS）一度跌約 14.7%，創 5 月 1 日以來最大盤中跌幅。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/272571259.md"
published_at: "2026-01-14T14:50:25.000Z"
---

# 眼科製藥和醫療技術公司 Glaukos Corporation（GKOS）一度跌約 14.7%，創 5 月 1 日以來最大盤中跌幅。

眼科製藥和醫療技術公司 Glaukos Corporation（GKOS）一度跌約 14.7%，創 5 月 1 日以來最大盤中跌幅。

### Related Stocks

- [GKOS.US - Glaukos](https://longbridge.com/zh-HK/quote/GKOS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Glaukos Q4 revenue rises on glaucoma sales | Glaukos reported a 36% year-over-year increase in Q4 revenue, primarily driven by strong glaucoma sales. However, the ad | [Link](https://longbridge.com/zh-HK/news/276168646.md) |
| Assessing Glaukos (GKOS) Valuation After FDA Clearance For Repeat Use Of iDose TR | Glaukos (GKOS) has gained attention following FDA approval for repeat use of its iDose TR glaucoma therapy. The stock is | [Link](https://longbridge.com/zh-HK/news/275504900.md) |
| AgelessRx Expands Access to Multi-Cancer Early Detection Solutions, in Honor of Cancer Prevention Month | AgelessRx is expanding access to its multi-cancer early detection solutions in honor of Cancer Prevention Month. This in | [Link](https://longbridge.com/zh-HK/news/276180967.md) |
| Glaukos (NYSE:GKOS) Director Sells $1,915,650.00 in Stock | Glaukos Corporation (NYSE:GKOS) Director Marc Stapley sold 15,000 shares for $1,915,650 on January 22nd, reducing his ow | [Link](https://longbridge.com/zh-HK/news/273781430.md) |
| Glaukos CEO Thomas William Burns Reports Disposal of Common Shares | Thomas William Burns, CEO of Glaukos Corporation, has reported the disposal of common shares of the company. The full fi | [Link](https://longbridge.com/zh-HK/news/273145771.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。